Drug
Krn7000
Krn7000: highest development phase Phase 1/2, developed by Kyowa Kirin. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KRN7000 NCT00352235 | Phase 1/2 | Chronic Hepatitis C |
Latest
No recent events.
Follow Krn7000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.